Catalyst Pharmaceuticals Inc
NASDAQ:CPRX 4:00:00 PM EDT
| Market Cap (Intraday) | 1.77B |
| Current PE | 21.26 |
| Forward PE | 11.07 |
| 2yr Forward PE | 8.94 |
| 10-Day MA | $16.15 |
| 50-Day MA | $15.88 |
| 200-Day MA | $14.02 |
Catalyst Pharmaceuticals Inc Stock, NASDAQ:CPRX
355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134
United States of America
Phone: +1.305.420.3200
Number of Employees: 82
Description
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton myasthenic syndrome, congenital myasthenic syndromes, MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.